Skip to main content

Indictment of monkey importers could disrupt U.S. drug and vaccine research

The indictment, which carries multiple felony charges, will likely exacerbate the shortage of these monkeys, used in everything from drug safety testing to vaccine research, says Dave O’Connor, a virologist at the University of Wisconsin, Madison, who studies infectious disease in cynomolgus macaques. Still, he says, the main priority should be stopping this illegal trade, both for the science and the animals themselves. “These sorts of unscrupulous actors give a black eye to an already heavily scrutinized industry.”